Suo J L
Department of Pharmacology, Beijing Medical University.
Sheng Li Ke Xue Jin Zhan. 1996 Jan;27(1):43-6.
We have systematically observed in the present study the anticarcinogenic and immunomodulatory effects of 4-Seleno-carageenan (Se-carra) as well as their possible mechanisms of actions in vivo and in vitro. It was found that se-carra had inhibitory effects on tumor growth in vivo and in vitro. The underlying mechanisms of this tumor suppressive effect may be related with the activation of macrophages, followed by the indirect priming of lymphocytes to release effector molecules such as IL-2, to express IL-2 receptors, and to selectively suppress the synthesis of macromolecules in tumor cells. The results imply that Se-carra has dual functions of tumor cell-killing effect and immunostimulating effect, therefore may serve as a novel immuno-cytotoxic anticarcinogenic drug.
在本研究中,我们系统地观察了4-硒代卡拉胶(Se-卡拉胶)的抗癌和免疫调节作用及其在体内和体外可能的作用机制。发现Se-卡拉胶在体内和体外对肿瘤生长均有抑制作用。这种肿瘤抑制作用的潜在机制可能与巨噬细胞的激活有关,随后间接引发淋巴细胞释放诸如白细胞介素-2等效应分子、表达白细胞介素-2受体,并选择性抑制肿瘤细胞中大分子的合成。结果表明,Se-卡拉胶具有肿瘤细胞杀伤作用和免疫刺激作用的双重功能,因此可能作为一种新型的免疫细胞毒性抗癌药物。